News
-
Danish Pharmacovigilance Update, January 2017
| 03 February 2017 |
The January issue of Danish Pharmacovigilance Update.
-
We are extending our opening hours
| 31 January 2017 |
From Wednesday 1 February 2017, we are extending our opening hours. This means that the reception will be open Monday to Friday from 8.30am to 3.30pm. You can also call us on our main telephone number during these hours.
-
Updating of summaries of product characteristics due to changed ATC codes for 2017
| 20 January 2017 |
Marketing authorisation holders of medicinal products authorised under the national procedure, the decentralised procedure as well as the mutual recognition procedure should be aware that some ATC codes have been changed for 2017.
-
Danish Pharmacovigilance Update, December 2016
| 06 January 2017 |
The December issue of Danish Pharmacovigilance Update.
-
Re-examination of the CVMP's decision to phase out zinc oxide for young pigs
| 05 January 2017 |
The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) will re-examine the decision to phase out medicinal products containing zinc oxide for the prevention of diarrhoea in young pigs.
-
Suspension of Europharma DK ApS’ authorisation to manufacture and distribute parallel imported medicinal products
| 03 January 2017 |
Today, 3 January 2017, the Danish Medicines Agency suspended Europharma DK ApS’ authorisation number 30308 issued on 23 March 2015 for the manufacturing and import of medicinal products and intermediate products (GMP authorisation).
-
New chair of PhVWP-V
| 20 December 2016 |
Lisbet Vesterager Borge, veterinarian, has been elected chair of the European Pharmacovigilance Working Party Veterinary (PhVWP-V).
-
Zinc oxide for young pigs to be phased out
| 19 December 2016 |
The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) has recommended to the European Commission that medicinal products containing zinc oxide for the prevention of diarrhoea in young pigs should be withdrawn from the market.
-
The Danish Medicines Agency launches new strategy
| 15 December 2016 |
The Danish Medicines Agency: Among Europe's best in class! This is our vision and we are now launching a strategy for how we are going to achieve the vision.
-
Phasing-out of the NeeS format for applications for marketing authorisations of medicinal products
| 12 December 2016 |
Due to an increasing number of requests, we would like to point out the phasing-out plan for NeeS and the transition to eCTD/VNeeS as outlined in the eSubmission Roadmap. The format requirements apply to applications for marketing authorisations for medicinal products as well as maintenance of these (variations, renewals etc.). The changes do not apply to parallel import and parallel distribution.
-
Danish Pharmacovigilance Update, November 2016
| 09 December 2016 |
The November issue of Danish Pharmacovigilance Update.
-
Interactive Adverse Drug Reaction overviews
| 08 December 2016 |
The Danish Medicines Agency has launched a new web-based database that researchers and other interested parties can use to search for reported suspected adverse reactions.
-
Twelve new substances on the list of euphoriant substances
| 30 November 2016 |
As of 24 November 2016, 12 new substances are included in the Danish executive order no. 557 of 31 May 2011 on euphoriant substances issued by the Danish Ministry of Health. The information is primarily relevant to companies authorised to deal with euphoriant substances.
-
How the HPV vaccine works
| 30 November 2016 |
The Danish Medicines Agency has made a short video graphic about the efficacy of the HPV vaccine.
-
Nikolai Brun appointed new Director of Division
| 24 November 2016 |
The Danish Medicines Agency strengthens its leadership team and appoints Nikolai Brun, MD and PhD, as Director of Division of the new Medical Evaluation & Biostatistics division.
-
Danish Pharmacovigilance Update, October 2016
| 15 November 2016 |
The October issue of Danish Pharmacovigilance Update.
-
Available time slots for DCP applications with Denmark as reference member state
| 28 October 2016 |
Companies wishing to apply for a marketing authorisation for a medicinal product can request a specified submission date (time slot). Time slots are available.
-
Experts for the European Pharmacopoeia's groups of experts and working parties
| 07 October 2016 |
A very large part of the work related to the drafting of new monographs for the European Pharmacopoeia (EDQM) is carried out by external experts in 75 groups of experts and working parties. Experts for the groups are appointed for a period of three years, and the EDQM is now seeking experts for the period from 2017 to 2019.
-
The Danish Medicines Agency to strengthen its leadership and professional focus
| 28 September 2016 |
A new division with medical expertise and a general strengthening of the leadership throughout the Agency. This is the essence of the organisational change which will take effect in the Danish Medicines Agency at the turn of the year.
-
Manufacturers and wholesale distributors must be contactable outside opening hours
| 22 September 2016 |
The Danish Medicines Agency will make calls to companies' main phone numbers, or emergency lines, to check that wholesale distributors and pharmaceutical manufacturers are contactable outside normal opening hours and during holidays.